 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption |
| Ha-Neui Kim, Jong-Ho Lee, Won Jong Jin, Zang Hee Lee |
|
jbm. 2012;19(2):111-120. Published online November 16, 2012 DOI: https://doi.org/10.11005/jbm.2012.19.2.111 |
|
α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption Journal of Bone Metabolism. 2012;19(2):111  α-Tocopheryl Succinate Inhibits Osteolytic Bone Metastasis of Breast Cancer by Suppressing Migration of Cancer Cells and Receptor Activator of Nuclear Factor-κB Ligand Expression of Osteoblasts Journal of Bone Metabolism. 2018;25(1):23 Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation Journal of Bone Metabolism. 2012;19(2):121 Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways Journal of Bone Metabolism. 2017;24(4):207 Osteoprotegerin (OPG) und Receptor Activator for Nuclear Factor kappaB Ligand (RANKL) als Risikofaktoren für Entstehung und Schweregrad einer Koronaren Herzerkrankung – ein Review Wiener Medizinische Wochenschrift. 2011;161(23-24):565-570 Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas Journal of Oral Pathology and Medicine. 2004;33(1):46-52 Crocin inhibits RANKL-induced osteoclast formation and bone resorption by suppressing NF-κB signaling pathway activation Immunobiology. 2017;222(4):597-603 Eleutherococcus sessiliflorus Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss Molecules. 2021;26(7):1886 Osteoprotegerin (OPG) and receptor activator of nuclear factor kappab ligand (RANKL) in pediatric chronic kidney disease (CKD) Bone. 2009;45:S65 Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) stimulates osteoclast differentiation in response to receptor activator of NF-κB ligand (RANKL) in osteoclast cells Bone. 2005;36(5):832-839 |
